Market Access Impact: HIV (EU5)

Market Access Impact: HIV (EU5)

Code: FW-21072016-15 | Published: Apr-2016 | Pages: 0 | FirstWord
Price :

* Required Fields



Can prescription barriers help the 2nd and 3rd place HIV brands catch up to the runaway market leader?

In the European HIV treatment market, the leading brand is comfortably ahead—but can market barriers help either of the 3rd-place contenders move up to the #2 spot.

Market Access Impact: HIV shows you which brands you’re losing share to, which brands you’re taking it from, and why.

Market Access Impact: HIV explores how cost concerns and other barriers affect market share for 8 major HIV treatments: Celsentri, Evotaz, Intelence, Isentress, Stribild, Triumeq, Truvada, and Viread.

You’ll find out which brands your brand is losing share to, which ones you’re taking it from, and why—information you can use to compete more effectively.

Not your market? Click here to see the US report

Get Answers to Key Questions about HIV Drug Brands

Celsentri (maraviroc; ViiV Healthcare): Which two leading FDCs does Celsentri take the most share from?
Evotaz (atazanavir/cobicistat; BMS): Which barrier do more than twice as many doctors experience with Evotaz than any other brand?
Intelence (etravirine; Janssen Therapeutics): Is limited availability or patient preference a bigger issue for doctors prescribing Intelence?
Isentress (raltegravir; Merck & Co.): Isentress and Stribild are prescribed equally. Which brand has better awareness among doctors?
Stribild (elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat; Gilead): Which market barrier costs Stribild more than twice as much share as any other?
Triumeq (abacavir/dolutegravir/lamivudine; ViiV Healthcare): Nearly half of Triumeq’s share loss is to one other brand. Which one?
Truvada (emtricitabine/tenofovir disoproxil fumarate; Gilead): Which barrier is responsible for over a third of Truvada’s net share gain?
Viread (tenofovir disoproxil fumarate; Gilead): Viread sees a net share gain from all but two surveyed brands. Which two?

Top Takeaways

Clear winners and losers: The two most prescribed brands have the biggest market share and barrier-related gains, while the two least prescribed brands have the smallest share and the greatest losses.
Half of brands benefit from barriers: But the two biggest winners see significantly bigger gains than the other two brands.
Brand awareness is high: With one exception, at least 97% of doctors surveyed are aware of any given brand.
Barrier effect is uneven: The number of doctors who experience the top 2 market barriers varies greatly from brand to brand.
No clear advantage for FDCs vs. monotherapies: Of the four most prescribed brands, two are fixed-dose products while the other two are monotherapies.
Cost and labelling issues have the greatest impact: Barriers related to guidelines and patient type restrictions affect more prescriptions than any others.
Barrier effect significant for “other” brands: Taken together, “other” brands have a greater market share than 3/4 of the surveyed brands, and see the third biggest net gain due to barriers.

Exploring Market Access Issues
Market Access Impact: HIV explores key issues affecting HIV drug manufacturers. You’ll learn:

How barriers affect market access:

What brands do doctors prescribe the most?
How many prescriptions do barriers affect?
Which barriers have the biggest effect?

How barriers affect your brand:

How many doctors prescribe your brand? How many don’t, but would consider it?
Why don’t doctors prescribe your brand? What do they prescribe instead?
Which competing brands does your brand take market share from?

A Report Based on Expert Knowledge

We surveyed 150 infectious disease specialists — 30 from each EU5 country (France, Italy, Germany, Spain, UK) — chosen from the largest community of validated physicians in the world.

All respondents have:

Been practicing for 2+ years
Prescribed at least one of the listed products
Seen at least 5 patients with melanoma in total in the last month

We conducted the survey between March 2nd and 9th, 2016.

At FirstWord, we stand behind our reports. If you're not completely satisfied, we’ll refund your money. Guaranteed.

Table of Contents

1 What are market barriers?
2 About this report
3 About the survey
4 Brands included in the survey
5 Executive summary

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]

2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal

3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

Browse similar reports by category:
Pharmaceuticals & Healthcare

Our Clients